Literature DB >> 977998

beta-Lactamase activity in Chromobacterium violaceum.

W E Farrar, N M O'dell.   

Abstract

A strain of Chromobacterium violaceum isolated from a fatally infected patient was found to produce a beta-lactamase. When the organism was grown in drug-free medium, beta-lactamase activity was barely detectable, but when it was grown in the presence of penicillin G, a much larger amount of activity was produced. The beta lactamase was active primarily against cephalosporins; it was sensitive to inhibition by cloxacillin but resistant to p-chloromercuribenzoate. Thus this enzyme closely resembled the common type of beta-lactamase found in Pseudomonas aeruginosa. The organism was relatively susceptible to ticarcillin, carbenicillin, and cefoxitin, which resected hydrolysis by its beta-lactamase, but was quite resistant to 11 other beta-lactam antibiotics. Production of the beta-lactamase appeared to be mediated by chromosomal genes.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 977998     DOI: 10.1093/infdis/134.3.290

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

Review 1.  Classification of beta-lactamases: groups 1, 2a, 2b, and 2b'.

Authors:  K Bush
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

Review 2.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

3.  Two cases of Chromobacterium violaceum infection after injury in a subtropical region.

Authors:  J Lee; J S Kim; C H Nahm; J W Choi; J Kim; S H Pai; K H Moon; K Lee; Y Chong
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

Review 4.  AmpC beta-lactamases.

Authors:  George A Jacoby
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

5.  Urinary tract infection by chromobacterium violaceum.

Authors:  Bichitrananda Swain; Sarita Otta; Kundan Kumar Sahu; Kirtika Panda; Subhrajita Rout
Journal:  J Clin Diagn Res       Date:  2014-08-20

6.  Chromobacterium violaceum Septicaemia and Urinary Tract Infection: Case Reports from a Tertiary Care Hospital in South India.

Authors:  Vishnu Kaniyarakkal; Shabana Orvankundil; Saradadevi Karunakaran Lalitha; Raji Thazhethekandi; Jahana Thottathil
Journal:  Case Rep Infect Dis       Date:  2016-09-22

7.  A scalable metabolite supplementation strategy against antibiotic resistant pathogen Chromobacterium violaceum induced by NAD+/NADH+ imbalance.

Authors:  Deepanwita Banerjee; Dharmeshkumar Parmar; Nivedita Bhattacharya; Avinash D Ghanate; Venkateswarlu Panchagnula; Anu Raghunathan
Journal:  BMC Syst Biol       Date:  2017-04-26

Review 8.  The Growing Genetic and Functional Diversity of Extended Spectrum Beta-Lactamases.

Authors:  Sadeeq Ur Rahman; Tariq Ali; Ijaz Ali; Nazir Ahmad Khan; Bo Han; Jian Gao
Journal:  Biomed Res Int       Date:  2018-03-26       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.